Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus

AIDS. 2007 Nov 30;21(18):2546-9. doi: 10.1097/QAD.0b013e3282f2a94f.

Abstract

The histological study on the reciprocal influence of chronic hepatitis C (HCV) and/or delta (HDV) on liver damage in a cohort of 134 HIV-HBV co-infected patients concluded on a significant association between HDV co-infection (noted in 13 patients) and Metavir F3-F4 liver fibrosis score [odds ratio (OR) = 7.08, 95% confidence interval (CI) = 1.06-47.28 for HBV-HDV, OR = 10.02, 95% CI = 1.03-97.42 for HBV-HCV-HDV, compared to OR = 1.76, 95% CI = 0.50-6.17 for HBV alone]. Co-treatment of other multiple viral hepatitis infections should also be taken into consideration, especially in the case of chronic HDV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cross-Sectional Studies
  • Female
  • HIV Infections / complications*
  • Hepatitis B, Chronic / complications
  • Hepatitis C, Chronic / complications
  • Hepatitis D, Chronic / complications
  • Hepatitis, Viral, Human / complications*
  • Humans
  • Liver Cirrhosis / virology*
  • Male
  • Middle Aged
  • Severity of Illness Index